2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow AUG Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II AVTX-803 - Leukocyte Adhesion Deficiency | Phase 3 | Recruiting | AUG Therapeutics | 2 | 2023-04-10 | 2026-05-01 |
| A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type II AVTX-803 (L-Fucose) - Leukocyte Adhesion Deficiency | Phase 3 | Recruiting | AUG Therapeutics | 4 | 2022-07-28 | 2026-05-01 |
Leukocyte adhesion deficiency type 1 (2)
Fucose (1)
United States (2)
David Deyle (1) · David Deyle, MD (1)